(Reuters Health) – In public mass shootings in the U.S., victims shot with a handgun were more likely to die than in the events associated with a rifle, according to a new study in the Journal of the American College of Surgeons.
“With public mass shootings rapidly on the rise, we wanted to know the reasons why people die and if any aspect is preventable,” said lead study author Dr. Babak Sarani of the George Washington University Center for Trauma and Critical Care in Washington, D.C.
Previous studies show that in mass shootings, about 45 percent of people who are wounded during the event die.
(Reuters Health) – Low fitness levels have long been tied to higher risk for heart problems. Now researchers say men’s cardiorespiratory fitness is tied to their risk for stroke as well.
Researchers in Norway followed 2,014 middle-aged men for more than 20 years. Those who were unfit for the whole study period, or who started out fit but became less so, were twice as likely to have a stroke as those who stayed fit or became fit, they reported in the journal Stroke.
NEW YORK (Reuters) – A former patient has filed the first lawsuit against a New Jersey surgery center that may have exposed nearly 3,800 patients to HIV and hepatitis due to poor sterilization and medication practices.
The HealthPlus Surgery Center in Saddle Brook recently told the patients that a state probe of its facilities found “lapses in infection control” and “the injection of medications” could have exposed them to the diseases.
A state report released on Friday said operating rooms at the center were not properly cleaned and surgical tools were sometimes found with “brown rust-like stains” before use.
(Reuters) – A U.S. healthcare worker who may have been exposed to the Ebola virus while treating patients in the Democratic Republic of Congo arrived in the United States on Saturday and was put in quarantine in Nebraska.
The medic, who is not exhibiting symptoms of Ebola, will remain under observation for up to two weeks at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska Medicine said in a statement.
The individual’s name was not released for privacy reasons.
(Reuters Health) – People who live in neighborhoods with more green spaces may have less stress, healthier blood vessels and a lower risk of heart attacks and strokes than residents of communities without many outdoor recreation areas, a small study suggests.
Trees and plants frame a building in the “eco-neighbourhood”, Clichy-Batignolles, one of several new ecological housing developments with low energy use and carbon emissions, in Paris, France, October 22, 2015. REUTERS/Benoit Tessier
(Reuters Health) – International migrants who relocate to high-income countries to work, study or join family members are less likely to die prematurely than people born in their new homelands, a research review suggests.
For the analysis, researchers examined data from 96 studies with mortality estimates for more than 15.2 million international migrants in 92 countries. Overall, migrants were about 30 percent less likely to experience premature death from all causes than other people in the general populations of the countries where they moved, the analysis found.
Robert and Tiffany Cano of San Tan Valley, Ariz., have a new marriage, a new house and a 10-month-old son, Brody, who is delighted by his ability to blow raspberries.
They also have a stack of medical bills that threatens to undermine it all.
In the months since their sturdy, brown-eyed boy was born, the Canos have acquired more than $12,000 in medical debt — so much that they need a spreadsheet to track what they owe to hospitals and doctors.
(Reuters Health) – Despite warnings that supplemental testosterone may raise the risk of stroke and heart attack, doctors continue to prescribe the hormone off-label to men with cardiovascular disease, a U.S. study finds.
After poring over 10 years of prescription data, researchers found that men with heart disease were no less likely than those without it to receive a testosterone prescription despite warnings from the Food and Drug Administration (FDA) in 2014 that the hormone might increase cardiovascular risk, researchers reported in JAMA Internal Medicine.